AbbVie Inc. (ABBV) › Capital ExpendituresAbbVie Inc. (ABBV) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2011: $356.00M2012: $333.00M2013: $491.00M2014: $612.00M2015: $532.00M2016: $479.00M2017: $529.00M2018: $638.00M2019: $552.00M2020: $798.00M2021: $787.00M2022: $695.00M2023: $777.00M2024: $974.00M2025: $1.21B$1.21B2011Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$1.21B+24.6%2024$974.00M+25.4%2023$777.00M+11.8%2022$695.00M-11.7%2021$787.00M-1.4%2020$798.00M+44.6%2019$552.00M-13.5%2018$638.00M+20.6%2017$529.00M+10.4%2016$479.00M-10.0%2015$532.00M-13.1%2014$612.00M+24.6%2013$491.00M+47.4%2012$333.00M-6.5%2011$356.00M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share